| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0011800 | Exon-Exon | chr18:9216756-9263886 | chr18:9216758-9263888 | 250 nt | 0.3240 |
| hsa_ANKRD12_0012500 | Intron-Exon-Intron | chr18:9221850-9239554 | chr18:9221852-9239556 | 250 nt | 0.3120 |
| hsa_ANKRD12_0012600 | Exon-Exon | chr18:9221850-9263886 | chr18:9221852-9263888 | 250 nt | 0.3400 |
| hsa_ANKRD12_0012700 | Exon-Exon | chr18:9221850-9275665 | chr18:9221852-9275667 | 250 nt | 0.3480 |
| hsa_ANKRD12_0012800 | Intron-Exon-Intron | chr18:9239475-9263886 | chr18:9239477-9263888 | 250 nt | 0.2840 |
| hsa_ANKRD12_0013500 | Exon-Exon | chr18:9254209-9258929 | chr18:9254211-9258931 | 250 nt | 0.3040 |
| hsa_ANKRD12_0013700 | Exon-Exon | chr18:9254209-9263886 | chr18:9254211-9263888 | 99 nt | 0.4040 |
| hsa_ANKRD12_0013600 | Exon-Exon | chr18:9254209-9279642 | chr18:9254211-9279644 | 250 nt | 0.2840 |
| hsa_chr18_0229300 | Intergenic-Intergenic | chr18:9255522-9257172 | chr18:9255524-9257174 | 1651 nt | 0.3404 |
| hsa_ANKRD12_0013800 | Exon-Exon | chr18:9255771-9255918 | chr18:9255773-9255920 | 148 nt | 0.2905 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].